451 |
ESTROFA-2: Stent Thrombosis with Zotarolimus-Eluting & Everolimus-Eluting Stents in CAD |
Jose de la Torre |
Dec. 09. 08 |
450 |
Western Denmark Heart Registry: Zotarolimus-Eluting vs. Sirolimus-Eluting Stents in CAD |
Leif Thuesen |
Dec. 09. 08 |
449 |
DIVERGE: Self-Expanding Drug-Eluting Bifurcation Stent Registry |
Stefan Verheye |
Dec. 09. 08 |
448 |
ISAR-TEST 2: Polymer-Free DES, Polymer-Based DES & Zotarolimus-Eluting Stents in CAD |
Robert A. Byrne |
Dec. 09. 08 |
447 |
BBC ONE: Single DES Provisional Strategy vs. Routine Dual DES for Bifurcation Lesions |
David Hildick-Smith |
Dec. 09. 08 |
446 |
SORT-OUT III: Zotarolimus-Eluting Stents vs. Sirolimus-Eluting Stents in CAD |
Jens Flensted Lassen |
Dec. 09. 08 |
445 |
PREPARE: Proximal Microcirculatory Protection in Patients with AMI Undergoing Primary PCI |
Karel Koch |
Dec. 09. 08 |
444 |
HORIZONS AMI: Bivalirudin vs. Unfractionated Heparin plus GPIIb/IIIa Inhibitors in STEMI [1] |
Roxana Mehran |
Dec. 09. 08 |
443 |
HORIZONS AMI AMI: Prospective Randomized Trials of Paclitaxel-Eluting Stents vs. BMS in Patients with STEMI |
Gregg W. Stone |
Dec. 09. 08 |
442 |
COOL RCN : Randomized Trail of Systemic Hypothermia for Prevention of Radiocontrast Nephropathy |
Gregg W. Stone |
Dec. 09. 08 |